Биофармацевтические исследования термочувствительной липосомальной лекарственной формы доксорубицина
Тазина Елизавета Владимировна, Meshcherikova Vv, Игнатьева Елена Владимировна et al. · Российский биотерапевтический журнал · 2009
Thermosensitive liposomes are capable to capture the drug and release it into the medium when heated up to 40 43 °C. The purpose of present work was preparation thermosensitive liposomes loaded with doxorubicin, their standardization and assessment of biological activity in vitro and in vivo. Thermosensitive liposomes were prepared by reverse evaporation method using phospholipids, lipid-grafted polyethylenglycol and cholesterol with their subsequent loading by doxorubicin based on the formation of ammonium gradient between the internal and external aqueous phase of liposomes. The efficacy of doxorubicin encapsulation in thermosensitive liposomes was 87 94 %, the diameter of vesicles was 165 ± 10 nm. The heating of thermoliposomal doxorubicin has resulted in more than 10fold decrease of cells growth rate in vitro. The tumor doubling time increased from 2 days in control group up to 11 days in the group of animals that were treated with local hyperthermia after administration of thermosensitive liposomes loaded with doxorubicin at dose of 9 mg/kg. The 50 % survival of animals in this group was 34 days. Based on data obtained, we conclude that both in vitro and in vivo thermoliposomal doxorubicin in combination with local hyperthermia has shown less toxicity and more efficiency compared to free doxorubicin
Cited by 0 works.